Table 2 Operative factors and findings (N = 70)^a

Operative factors

Indication

 MR

49 (70 %)

 MS

19 (27 %)

 Endocarditis

10 (14.2 %)

Attempted repair

 Yes

7 (10 %)

 No

63 (90 %)

Minimally invasive Magna valve implantation

 Yes

1 (1.4 %)

 No (i.e., full sternotomy)

69 (99 %)

Technique for Magna valve implantation

 Transseptal approach

49 (70 %)

 Left atriotomy

21 (30 %)

 Subvalvular leaflet preservation

56 (80 %)

Magna valve size^b (mm)

28 ± 0.3

 25

18 (26 %)

 27

16 (23 %)

 29

19 (27 %)

 31

16 (23 %)

 33

1 (1.4 %)

Findings

 Rheumatic disease

12 (17 %)

 Myxomatous disease

4 (5.7 %)

 Ruptured chordae

5 (7.1 %)

 Degenerative disease

28 (40 %)

 Vegetations

10 (14 %)

 MAC

38 (54 %)

 Ischemic MR (posterior restriction)

3 (4.3 %)

Concomitant procedures

 Any

58 (83 %)

 CABG

6 (8.6 %)

 AVR, TVR, ASD repair, and/or myectomy

33 (47 %)

 CABG + AVR, TVR, ASD repair, and/or myectomy

11 (16 %)

 AVR

24 (34 %)

 Triple valve procedures

6 (8.6 %)

 Antiarrhythmic procedure (Cox maze procedure, PVI, and/or LAAL)

7 (10 %)